{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T18:38:18Z","timestamp":1782239898908,"version":"3.54.5"},"reference-count":152,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>Treatment of hepatic diseases presents a significant challenge due to their diverse\nnature. Ginsenosides, bioactive compounds derived from the root of Panax ginseng and widely\nused in traditional Chinese medicine, offer multifaceted protection to various organs in the body.\nTheir versatile effects, including antioxidant, anti-inflammatory, anti-apoptotic and more, make\nthem a promising approach for addressing hepatic disorders. This review explores the intricate\nmolecular mechanisms and properties of ginsenosides in the prevention and treatment of liver\nailments, from mild conditions to severe damage and liver fibrosis. Given the increasing prevalence\nof hepatic disorders, this article sheds light on the significant pharmaceutical potential of\nginsenosides in the realm of hepatic disease management.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0113892010291326240214095327","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T04:08:55Z","timestamp":1709266135000},"page":"957-971","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Hepatoprotective Effects of Ginsenoside from Ginseng: A Review of Molecular Mechanisms and Therapeutic Potentials"],"prefix":"10.2174","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7413-1810","authenticated-orcid":true,"given":"Seyed Reza","family":"Taha","sequence":"first","affiliation":[{"name":"Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4743-8355","authenticated-orcid":true,"given":"Andarz","family":"Fazlollahpour-Naghibi","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Tropical\nMedicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2079-793X","authenticated-orcid":true,"given":"Mahdieh Shariat","family":"Zadeh","sequence":"additional","affiliation":[{"name":"Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2824-8446","authenticated-orcid":true,"given":"Kimia","family":"Bagheri","sequence":"additional","affiliation":[{"name":"Infectious Diseases and Tropical\nMedicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0263-8895","authenticated-orcid":true,"given":"Hamed Rahmani","family":"Youshanlouei","sequence":"additional","affiliation":[{"name":"Department\nof Hematology and Oncology, University of Chicago, Chicago, IL, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3353-1102","authenticated-orcid":true,"given":"Reza","family":"Mosaddeghi-Heris","sequence":"additional","affiliation":[{"name":"Neurosciences Research Center, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8448-1539","authenticated-orcid":true,"given":"Seyyed Sina","family":"Hejazian","sequence":"additional","affiliation":[{"name":"Neurosciences Research Center, Tabriz University\nof Medical Sciences, Tabriz, Iran"},{"name":"Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9909-1683","authenticated-orcid":true,"given":"Amirreza","family":"Khalaji","sequence":"additional","affiliation":[{"name":"Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran"},{"name":"Connective Tissue Diseases Research\nCenter, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0134-5980","authenticated-orcid":true,"given":"Seyedeh Shaghayegh","family":"Alavi","sequence":"additional","affiliation":[{"name":"Bioprocess Engineering\nLaboratory (BPEL), Department of Food Science, Engineering &amp; Technology, Faculty of Agricultural Engineering\n&amp; Technology, University of Tehran, P.O. Box 4111, Karaj, 31587-77871, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1761-0684","authenticated-orcid":true,"given":"Payam","family":"Fattahi","sequence":"additional","affiliation":[{"name":"School of Medicine, Shahid\nBeheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6454-8145","authenticated-orcid":true,"given":"Saba","family":"Mehrtabar","sequence":"additional","affiliation":[{"name":"Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran"},{"name":"Connective Tissue Diseases Research\nCenter, Tabriz University of Medical Sciences, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/s41580-018-0096-9","volume":"20","author":"Reinke H.","year":"2019","unstructured":"Reinke H.; Asher G.; Crosstalk between metabolism and circadian clocks. Nat Rev Mol Cell Biol  2019,20(4),227-241","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"Asrani S.K.","year":"2019","unstructured":"Asrani S.K.; Devarbhavi H.; Eaton J.; Kamath P.S.; Burden of liver diseases in the world. J Hepatol  2019,70(1),151-171","journal-title":"J Hepatol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"121131","DOI":"10.1016\/j.lfs.2022.121131","volume":"310","author":"Ibrahim I.M.","year":"2022","unstructured":"Ibrahim I.M.; Althagafy H.S.; Abd-alhameed E.K.; Al-Thubiani W.S.; Hassanein E.H.M.; Promising hepatoprotective effects of lycopene in different liver diseases. Life Sci  2022,310,121131","journal-title":"Life Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"26087","DOI":"10.3390\/ijms161125942","volume":"16","author":"Li S.","year":"2015","unstructured":"Li S.; Tan H.Y.; Wang N.; Zhang Z.J.; Lao L.; Wong C.W.; Feng Y.; The role of oxidative stress and antioxidants in liver diseases. Int J Mol Sci  2015,16(11),26087-26124","journal-title":"Int J Mol Sci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S0168-8278(02)00429-4","volume":"38","author":"Friedman S.L.","year":"2003","unstructured":"Friedman S.L.; Liver fibrosis \u2013 from bench to bedside. J Hepatol  2003,38(Suppl. 1),38-53","journal-title":"J Hepatol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"S194","DOI":"10.1002\/hep.21065","volume":"43","author":"Feld J.J.","year":"2006","unstructured":"Feld J.J.; Liang J.T.; Hepatitis C - identifying patients with progressive liver injury. Hepatology  2006,43(2)(Suppl. 1),S194-S206","journal-title":"Hepatology"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"173","DOI":"10.5009\/gnl16477","volume":"11","author":"Stickel F.","year":"2017","unstructured":"Stickel F.; Datz C.; Hampe J.; Bataller R.; Pathophysiology and management of alcoholic liver disease: Update 2016. Gut Liver  2017,11(2),173-188","journal-title":"Gut Liver"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/jms.370","volume":"37","author":"Cai Z.","year":"2002","unstructured":"Cai Z.; Lee F.S.C.; Wang X.R.; Yu W.J.; A capsule review of recent studies on the application of mass spectrometry in the analysis of Chinese medicinal herbs. J Mass Spectrom  2002,37(10),1013-1024","journal-title":"J Mass Spectrom"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0006-2952(99)00212-9","volume":"58","author":"Attele A.S.","year":"1999","unstructured":"Attele A.S.; Wu J.A.; Yuan C.S.; Ginseng pharmacology. Biochem Pharmacol  1999,58(11),1685-1693","journal-title":"Biochem Pharmacol"},{"key":"ref=10","first-page":"1","volume":"55","author":"Christensen L.P.","year":"2009","unstructured":"Christensen L.P.; Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv Food Nutr Res  2009,55,1-99","journal-title":"Adv Food Nutr Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jgr.2022.03.008","volume":"46","author":"Yi Y.S.","year":"2022","unstructured":"Yi Y.S.; Potential benefits of ginseng against COVID-19 by targeting inflammasomes. J Ginseng Res  2022,46(6),722-730","journal-title":"J Ginseng Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"106099","DOI":"10.1016\/j.phrs.2022.106099","volume":"177","author":"Zarneshan S.N.","year":"2022","unstructured":"Zarneshan S.N.; Fakhri S.; Khan H.; Targeting Akt\/CREB\/BDNF signaling pathway by ginsenosides in neurodegenerative diseases: A mechanistic approach. Pharmacol Res  2022,177,106099","journal-title":"Pharmacol Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jgr.2020.02.004","volume":"45","author":"Ratan Z.A.","year":"2021","unstructured":"Ratan Z.A.; Haidere M.F.; Hong Y.H.; Park S.H.; Lee J.O.; Lee J.; Cho J.Y.; Pharmacological potential of ginseng and its major component ginsenosides. J Ginseng Res  2021,45(2),199-210","journal-title":"J Ginseng Res"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1039\/c0np00057d","volume":"28","author":"Qi L.W.","year":"2011","unstructured":"Qi L.W.; Wang C.Z.; Yuan C.S.; Isolation and analysis of ginseng: Advances and challenges. Nat Prod Rep  2011,28(3),467-495","journal-title":"Nat Prod Rep"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jgr.2017.10.004","volume":"42","author":"Kim J.H.","year":"2018","unstructured":"Kim J.H.; Pharmacological and medical applications of Panax ginseng and ginsenosides: A review for use in cardiovascular diseases. J Ginseng Res  2018,42(3),264-269","journal-title":"J Ginseng Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s43440-020-00213-z","volume":"73","author":"Kang Z.","year":"2021","unstructured":"Kang Z.; Zhonga Y.; Wu T.; Huang J.; Zhao H.; Liu D.; Ginsenoside from ginseng: A promising treatment for inflammatory bowel disease. Pharmacol Rep  2021,73(3),700-711","journal-title":"Pharmacol Rep"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12374-023-09384-7","volume":"66","author":"Mohanan P.","year":"2023","unstructured":"Mohanan P.; Yang T.J.; Song Y.H.; Genes and regulatory mechanisms for ginsenoside biosynthesis. J Plant Biol  2023,66(1),87-97","journal-title":"J Plant Biol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.biotechadv.2015.03.001","volume":"33","author":"Kim Y.J.","year":"2015","unstructured":"Kim Y.J.; Zhang D.; Yang D.C.; Biosynthesis and biotechnological production of ginsenosides. Biotechnol Adv  2015,33(6),717-735","journal-title":"Biotechnol Adv"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s10068-017-0159-2","volume":"26","author":"Jung J.","year":"2017","unstructured":"Jung J.; Lee N.K.; Paik H.D.; Bioconversion, health benefits, and application of ginseng and red ginseng in dairy products. Food Sci Biotechnol  2017,26(5),1155-1168","journal-title":"Food Sci Biotechnol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.jgr.2013.11.015","volume":"38","author":"Le T.H.V.","year":"2014","unstructured":"Le T.H.V.; Lee S.Y.; Kim T.R.; Kim J.Y.; Kwon S.W.; Nguyen N.K.; Park J.H.; Nguyen M.D.; Processed Vietnamese ginseng: Preliminary results in chemistry and biological activity. J Ginseng Res  2014,38(2),154-159","journal-title":"J Ginseng Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"112813","DOI":"10.1016\/j.jpba.2019.112813","volume":"177","author":"Yang W.","year":"2020","unstructured":"Yang W.; Shi X.; Yao C.; Huang Y.; Hou J.; Han S.; Feng Z.; Wei W.; Wu W.; Guo D.; A novel neutral loss\/product ion scan-incorporated integral approach for the untargeted characterization and comparison of the carboxyl-free ginsenosides from Panax ginseng, Panax quinquefolius, and Panax notoginseng. J Pharm Biomed Anal  2020,177,112813","journal-title":"J Pharm Biomed Anal"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"4390","DOI":"10.3390\/molecules25194390","volume":"25","author":"Piao X.M.","year":"2020","unstructured":"Piao X.M.; Huo Y.; Kang J.P.; Mathiyalagan R.; Zhang H.; Yang D.U.; Kim M.; Yang D.C.; Kang S.C.; Wang Y.P.; Diversity of ginsenoside profiles produced by various processing technologies. Molecules  2020,25(19),4390","journal-title":"Molecules"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1136\/gutjnl-2019-318813","volume":"69","author":"Younossi Z.M.","year":"2020","unstructured":"Younossi Z.M.; Stepanova M.; Younossi Y.; Golabi P.; Mishra A.; Rafiq N.; Henry L.; Epidemiology of chronic liver diseases in the USA in the past three decades. Gut  2020,69(3),564-568","journal-title":"Gut"},{"key":"ref=24","first-page":"2809","volume":"20","author":"Le M.H.","year":"2022","unstructured":"Le M.H.; Yeo Y.H.; Li X.; Li J.; Zou B.; Wu Y.; Global NAFLD prevalence: A systematic review and meta-analysis. Clinical gastroenterology and hepatology. AGA  2022,20(12),2809-2817","journal-title":"AGA"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1053\/j.gastro.2016.02.066","volume":"150","author":"Machado M.V.","year":"2016","unstructured":"Machado M.V.; Diehl A.M.; Pathogenesis of nonalcoholic steatohepatitis. Gastroenterology  2016,150(8),1769-1777","journal-title":"Gastroenterology"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"Chalasani N.","year":"2018","unstructured":"Chalasani N.; Younossi Z.; Lavine J.E.; Charlton M.; Cusi K.; Rinella M.; Harrison S.A.; Brunt E.M.; Sanyal A.J.; The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the american association for the study of liver diseases. Hepatology  2018,67(1),328-357","journal-title":"Hepatology"},{"key":"ref=27","first-page":"544","volume":"56","author":"Aguilera-M\u00e9ndez A.","year":"2019","unstructured":"Aguilera-M\u00e9ndez A.; [Nonalcoholic hepatic steatosis: A silent disease] Rev Med Inst Mex Seguro Soc  2019,56(6),544-549","journal-title":"Rev Med Inst Mex Seguro Soc"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/kjm2.12118","volume":"35","author":"Pan Y.W.","year":"2019","unstructured":"Pan Y.W.; Tsai M.C.; Yang Y.J.; Chen M.Y.; Chen S.Y.; Chou Y.Y.; The relationship between nonalcoholic fatty liver disease and pediatric congenital hypothyroidism patients. Kaohsiung J Med Sci  2019,35(12),778-786","journal-title":"Kaohsiung J Med Sci"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13613-018-0404-8","volume":"8","author":"Rambaud J.","year":"2018","unstructured":"Rambaud J.; Lidouren F.; Sage M.; Kohlhauer M.; Nadeau M.; Fortin-Pellerin \u00c9.; Micheau P.; Zilberstein L.; Mongardon N.; Ricard J.D.; Terada M.; Bruneval P.; Berdeaux A.; Ghaleh B.; Walti H.; Tissier R.; Hypothermic total liquid ventilation after experimental aspiration-associated acute respiratory distress syndrome. Ann Intensive Care  2018,8(1),57","journal-title":"Ann Intensive Care"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11894-020-00786-y","volume":"22","author":"Lin C.H.","year":"2020","unstructured":"Lin C.H.; Kohli R.; Emerging new diagnostic modalities and therapies of nonalcoholic fatty liver disease. Curr Gastroenterol Rep  2020,22(10),52","journal-title":"Curr Gastroenterol Rep"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/j.foodchem.2013.05.019","volume":"141","author":"Zhang S.","year":"2013","unstructured":"Zhang S.; Zheng L.; Dong D.; Xu L.; Yin L.; Qi Y.; Han X.; Lin Y.; Liu K.; Peng J.; Effects of flavonoids from Rosa laevigata Michx fruit against high-fat diet-induced non-alcoholic fatty liver disease in rats. Food Chem  2013,141(3),2108-2116","journal-title":"Food Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12944-023-01787-2","volume":"22","author":"Chen X.","year":"2023","unstructured":"Chen X.; Xue W.; Zhang J.; Peng J.; Huang W.; Ginsenoside Rg1 attenuates the NASH phenotype by regulating the miR-375-3p\/ATG2B\/PTEN-AKT axis to mediate autophagy and pyroptosis. Lipids Health Dis  2023,22(1),22","journal-title":"Lipids Health Dis"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/7514802","volume":"2019","author":"Xiao Q.","year":"2019","unstructured":"Xiao Q.; Zhang S.; Yang C.; Du R.; Zhao J.; Li J.; Xu Y.; Qin Y.; Gao Y.; Huang W.; Ginsenoside Rg1 ameliorates palmitic acid-induced hepatic steatosis and inflammation in hepG2 cells via  the AMPK\/NF- \u03ba B Pathway. Int J Endocrinol  2019,2019,1-11","journal-title":"Int J Endocrinol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"41144","DOI":"10.1038\/srep41144","volume":"7","author":"Chen X.J.","year":"2017","unstructured":"Chen X.J.; Liu W.J.; Wen M.L.; Liang H.; Wu S.M.; Zhu Y.Z.; Zhao J.Y.; Dong X.Q.; Li M.G.; Bian L.; Zou C.G.; Ma L.Q.; Ameliorative effects of compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats. Sci Rep  2017,7(1),41144","journal-title":"Sci Rep"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.tem.2017.05.004","volume":"28","author":"Day E.A.","year":"2017","unstructured":"Day E.A.; Ford R.J.; Steinberg G.R.; AMPK as a therapeutic target for treating metabolic diseases. Trends Endocrinol Metab  2017,28(8),545-560","journal-title":"Trends Endocrinol Metab"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1039\/D1FO03026D","volume":"13","author":"Zhang J.","year":"2022","unstructured":"Zhang J.; Ma X.; Fan D.; Ginsenoside CK ameliorates hepatic lipid accumulation via  activating the LKB1\/AMPK pathway in vitro and in vivo. Food Funct  2022,13(3),1153-1167","journal-title":"Food Funct"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3904\/kjim.2015.208","volume":"33","author":"Hwang Y.C.","year":"2018","unstructured":"Hwang Y.C.; Oh D.H.; Choi M.C.; Lee S.Y.; Ahn K.J.; Chung H.Y.; Lim S.J.; Chung S.H.; Jeong I.K.; Compound K attenuates glucose intolerance and hepatic steatosis through AMPK-dependent pathways in type 2 diabetic OLETF rats. Korean J Intern Med  2018,33(2),347-355","journal-title":"Korean J Intern Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1530\/JOE-17-0233","volume":"235","author":"Lee J.B.","year":"2017","unstructured":"Lee J.B.; Yoon S.J.; Lee S.H.; Lee M.S.; Jung H.; Kim T.D.; Yoon S.R.; Choi I.; Kim I.S.; Chung S.W.; Lee H.G.; Min J.K.; Park Y.J.; Ginsenoside Rg3 ameliorated HFD-induced hepatic steatosis through downregulation of STAT5-PPAR\u03b3. J Endocrinol  2017,235(3),223-235","journal-title":"J Endocrinol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.3390\/foods12132492","volume":"12","author":"Yang S.","year":"2023","unstructured":"Yang S.; Duan Z.; Zhang S.; Fan C.; Zhu C.; Fu R.; Ma X.; Fan D.; Ginsenoside Rh4 improves hepatic lipid metabolism and inflammation in a model of nafld by targeting the gut liver axis and modulating the fxr signaling pathway. Foods  2023,12(13),2492","journal-title":"Foods"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2174\/1389201020666190311143554","volume":"20","author":"Kim J.C.","year":"2019","unstructured":"Kim J.C.; Jeon J.Y.; Yang W.; Kim C.H.; Eom D.W.; Combined amelioration of ginsenoside (Rg1, Rb1, and Rg3)-enriched korean red ginseng and probiotic lactobacillus on non-alcoholic fatty liver disease. Curr Pharm Biotechnol  2019,20(3),222-231","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.3390\/molecules24101856","volume":"24","author":"Metwaly A.M.","year":"2019","unstructured":"Metwaly A.M.; Lianlian Z.; Luqi H.; Deqiang D.; Black ginseng and its saponins: Preparation, phytochemistry and pharmacological effects. Molecules  2019,24(10),1856","journal-title":"Molecules"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/antiox10010062","volume":"10","author":"An M.Y.","year":"2021","unstructured":"An M.Y.; Lee S.R.; Hwang H.J.; Yoon J.G.; Lee H.J.; Cho J.A.; Antioxidant and anti-inflammatory effects of korean black ginseng extract through ER stress pathway. Antioxidants  2021,10(1),62","journal-title":"Antioxidants"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"e202200719","DOI":"10.1002\/cbdv.202200719","volume":"19","author":"Wei W.","year":"2022","unstructured":"Wei W.; Liu L.; Liu X.; Tao Y.; Zhao X.; Gong J.; Wang Y.; Liu S.; Exploring the therapeutic effects of black ginseng on non\u2010alcoholic fatty liver disease by using network pharmacology and molecular docking. Chem Biodivers  2022,19(10),e202200719","journal-title":"Chem Biodivers"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"984019","DOI":"10.3389\/fmicb.2022.984019","volume":"13","author":"Luo D.","year":"2022","unstructured":"Luo D.; Yang L.; Pang H.; Zhao Y.; Li K.; Rong X.; Guo J.; Tianhuang formula reduces the oxidative stress response of NAFLD by regulating the gut microbiome in mice. Front Microbiol  2022,13,984019","journal-title":"Front Microbiol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1111\/liv.12287","volume":"33","author":"Kim M.S.","year":"2013","unstructured":"Kim M.S.; Lee K.T.; Iseli T.J.; Hoy A.J.; George J.; Grewal T.; Roufogalis B.D.; Compound K modulates fatty acid\u2010induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes. Liver Int  2013,33(10),1583-1593","journal-title":"Liver Int"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1021\/jf802867b","volume":"57","author":"Kim D.Y.","year":"2009","unstructured":"Kim D.Y.; Yuan H.D.; Chung I.K.; Chung S.H.; Compound K, intestinal metabolite of ginsenoside, attenuates hepatic lipid accumulation via  AMPK activation in human hepatoma cells. J Agric Food Chem  2009,57(4),1532-1537","journal-title":"J Agric Food Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1248\/bpb.b18-00132","volume":"41","author":"Xu Y.","year":"2018","unstructured":"Xu Y.; Yang C.; Zhang S.; Li J.; Xiao Q.; Huang W.; Ginsenoside Rg1 protects against non-alcoholic fatty liver disease by ameliorating lipid peroxidation, endoplasmic reticulum stress, and inflammasome activation. Biol Pharm Bull  2018,41(11),1638-1644","journal-title":"Biol Pharm Bull"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1080\/09168451.2020.1793293","volume":"84","author":"Gao Y.","year":"2020","unstructured":"Gao Y.; Zhang S.; Li J.; Zhao J.; Xiao Q.; Zhu Y.; Zhang J.; Huang W.; Effect and mechanism of ginsenoside Rg1-regulating hepatic steatosis in HepG2 cells induced by free fatty acid. Biosci Biotechnol Biochem  2020,84(11),2228-2240","journal-title":"Biosci Biotechnol Biochem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"118986","DOI":"10.1016\/j.lfs.2020.118986","volume":"267","author":"Gu D.","year":"2021","unstructured":"Gu D.; Yi H.; Jiang K.; Fakhar S.H.; Shi J.; He Y.; Liu B.; Guo Y.; Fan X.; Li S.; Transcriptome analysis reveals the efficacy of ginsenoside-Rg1 in the treatment of nonalcoholic fatty liver disease. Life Sci  2021,267,118986","journal-title":"Life Sci"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/2919034","volume":"2016","author":"Chen Z.","year":"2016","unstructured":"Chen Z.; Li C.; Yang C.; Zhao R.; Mao X.; Yu J.; Lipid regulation effects of raw and processed notoginseng radix et rhizome on steatotic hepatocyte l02 cell. BioMed Res Int  2016,2016,1-9","journal-title":"BioMed Res Int"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3892\/mmr.2022.12694","volume":"25","author":"Li G.","year":"2022","unstructured":"Li G.; Xie H.; Cao X.; Ma C.; Li Y.; Chen L.; Ginsenoside Rg1 exerts anti apoptotic effects on non alcoholic fatty liver cells by downregulating the expression of SGPL1. Mol Med Rep  2022,25(5),178","journal-title":"Mol Med Rep"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"117776","DOI":"10.1016\/j.lfs.2020.117776","volume":"254","author":"Qi R.","year":"2020","unstructured":"Qi R.; Jiang R.; Xiao H.; Wang Z.; He S.; Wang L.; Wang Y.; Ginsenoside Rg1 protects against d-galactose induced fatty liver disease in a mouse model via  FOXO1 transcriptional factor. Life Sci  2020,254,117776","journal-title":"Life Sci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"10878","DOI":"10.1021\/acsomega.0c00529","volume":"5","author":"Hou Y.","year":"2020","unstructured":"Hou Y.; Gu D.; Peng J.; Jiang K.; Li Z.; Shi J.; Yang S.; Li S.; Fan X.; Ginsenoside Rg1 regulates liver lipid factor metabolism in NAFLD model rats. ACS Omega  2020,5(19),10878-10890","journal-title":"ACS Omega"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/2315230","volume":"2020","author":"Song B.","year":"2020","unstructured":"Song B.; Sun Y.; Chu Y.; Wang J.; Zheng H.; Liu L.; Cai W.; Zhang H.; Ginsenoside Rb1 alleviated high-fat-diet-induced hepatocytic apoptosis via  peroxisome proliferator-activated receptor \u03b3. BioMed Res Int  2020,2020,1-9","journal-title":"BioMed Res Int"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1021\/acs.jafc.0c00833","volume":"68","author":"Cheng B.","year":"2020","unstructured":"Cheng B.; Gao W.; Wu X.; Zheng M.; Yu Y.; Song C.; Miao W.; Yang Z.; He Y.; Liu C.; Yang W.; Yang X.; Li Y.; Zhang F.; Gao Y.; Ginsenoside Rg2 ameliorates high-fat diet-induced metabolic disease through SIRT1. J Agric Food Chem  2020,68(14),4215-4226","journal-title":"J Agric Food Chem"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.3390\/nu11122963","volume":"11","author":"Choi S.Y.","year":"2019","unstructured":"Choi S.Y.; Park J.S.; Shon C.H.; Lee C.Y.; Ryu J.M.; Son D.J.; Hwang B.Y.; Yoo H.S.; Cho Y.C.; Lee J.; Kim J.W.; Roh Y.S.; Fermented korean red ginseng extract enriched in Rd and Rg3 protects against non-alcoholic fatty liver disease through regulation of mTORC1. Nutrients  2019,11(12),2963","journal-title":"Nutrients"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3390\/ijms18051063","volume":"18","author":"Huang Q.","year":"2017","unstructured":"Huang Q.; Wang T.; Yang L.; Wang H.Y.; Ginsenoside Rb2 alleviates hepatic lipid accumulation by restoring autophagy via  induction of sirt1 and activation of AMPK. Int J Mol Sci  2017,18(5),1063","journal-title":"Int J Mol Sci"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1124\/jpet.120.000435","volume":"377","author":"Jiang L.","year":"2021","unstructured":"Jiang L.; Li W.; Zhuang T.; Yu J.; Sun S.; Ju Z.; Wang Z.; Ding L.; Yang L.; Ginsenoside Ro ameliorates high-fat diet\u2013induced obesity and insulin resistance in mice via  activation of the G Protein\u2013Coupled Bile Acid Receptor 5 Pathway. J Pharmacol Exp Ther  2021,377(3),441-451","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3390\/nu13030856","volume":"13","author":"Wang F.","year":"2021","unstructured":"Wang F.; Park J.S.; Ma Y.; Ma H.; Lee Y.J.; Lee G.R.; Yoo H.S.; Hong J.T.; Roh Y.S.; Ginseng saponin enriched in Rh1 and Rg2 ameliorates nonalcoholic fatty liver disease by inhibiting inflammasome activation. Nutrients  2021,13(3),856","journal-title":"Nutrients"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.3390\/ijms21124534","volume":"21","author":"Kim D.E.","year":"2020","unstructured":"Kim D.E.; Chang B.Y.; Jeon B.M.; Baek J.I.; Kim S.C.; Kim S.Y.; SGL 121 attenuates nonalcoholic fatty liver disease through adjusting lipid metabolism through AMPK signaling pathway. Int J Mol Sci  2020,21(12),4534","journal-title":"Int J Mol Sci"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"112927","DOI":"10.1016\/j.jep.2020.112927","volume":"259","author":"Roh E.","year":"2020","unstructured":"Roh E.; Hwang H.J.; Kim J.W.; Hong S.; Kim J.A.; Lee Y.B.; Choi K.M.; Baik S.H.; Yoo H.J.; Ginsenoside Mc1 improves liver steatosis and insulin resistance by attenuating ER stress. J Ethnopharmacol  2020,259,112927","journal-title":"J Ethnopharmacol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"110347","DOI":"10.1016\/j.biopha.2020.110347","volume":"129","author":"Lu H.","year":"2020","unstructured":"Lu H.; Yuan X.; Zhang Y.; Han M.; Liu S.; Han K.; Liang P.; Cheng J.; HCBP6 deficiency exacerbates glucose and lipid metabolism disorders in non-alcoholic fatty liver mice. Biomed Pharmacother  2020,129,110347","journal-title":"Biomed Pharmacother"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"622841","DOI":"10.3389\/fphar.2021.622841","volume":"12","author":"Liang W.","year":"2021","unstructured":"Liang W.; Zhou K.; Jian P.; Chang Z.; Zhang Q.; Liu Y.; Xiao S.; Zhang L.; Ginsenosides improve nonalcoholic fatty liver disease via  integrated regulation of gut microbiota, inflammation and energy homeostasis. Front Pharmacol  2021,12,622841","journal-title":"Front Pharmacol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jgr.2020.07.004","volume":"45","author":"Hong J.T.","year":"2021","unstructured":"Hong J.T.; Lee M.J.; Yoon S.J.; Shin S.P.; Bang C.S.; Baik G.H.; Kim D.J.; Youn G.S.; Shin M.J.; Ham Y.L.; Suk K.T.; Kim B.S.; Effect of Korea red ginseng on nonalcoholic fatty liver disease: An association of gut microbiota with liver function. J Ginseng Res  2021,45(2),316-324","journal-title":"J Ginseng Res"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"112879","DOI":"10.1016\/j.biopha.2022.112879","volume":"149","author":"Chen L.","year":"2022","unstructured":"Chen L.; Wang L.; Ao W.; Chen Y.; Li S.; Huang Z.; Yu D.; Dong Y.; Gu J.; Zeng H.; Bioinformatics study of the potential therapeutic effects of ginsenoside Rf in reversing nonalcoholic fatty liver disease. Biomed Pharmacother  2022,149,112879","journal-title":"Biomed Pharmacother"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"830","DOI":"10.2174\/1389200219666180523095355","volume":"19","author":"Kuna L.","year":"2018","unstructured":"Kuna L.; Bozic I.; Kizivat T.; Bojanic K.; Mrso M.; Kralj E.; Smolic R.; Wu G.Y.; Smolic M.; Models of drug induced liver injury (dili) \u2013 current issues and future perspectives. Curr Drug Metab  2018,19(10),830-838","journal-title":"Curr Drug Metab"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3350\/cmh.2012.18.3.249","volume":"18","author":"Suk K.T.","year":"2012","unstructured":"Suk K.T.; Kim D.J.; Drug-induced liver injury: present and future. Clin Mol Hepatol  2012,18(3),249-257","journal-title":"Clin Mol Hepatol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1111\/liv.15262","volume":"42","author":"Li X.","year":"2022","unstructured":"Li X.; Tang J.; Mao Y.; Incidence and risk factors of drug\u2010induced liver injury. Liver Int  2022,42(9),1999-2014","journal-title":"Liver Int"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"106361","DOI":"10.1016\/j.phrs.2022.106361","volume":"183","author":"Sun Y.","year":"2022","unstructured":"Sun Y.; Zhang Y.; Xie L.; Rong F.; Zhu X.; Xie J.; Zhou H.; Xu T.; Progress in the treatment of drug-induced liver injury with natural products. Pharmacol Res  2022,183,106361","journal-title":"Pharmacol Res"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.redox.2018.04.019","volume":"17","author":"Yan M.","year":"2018","unstructured":"Yan M.; Huo Y.; Yin S.; Hu H.; Mechanisms of acetaminophen-induced liver injury and its implications for therapeutic interventions. Redox Biol  2018,17,274-283","journal-title":"Redox Biol"},{"key":"ref=71","first-page":"131","volume":"4","author":"Yoon E.","year":"2016","unstructured":"Yoon E.; Babar A.; Choudhary M.; Kutner M.; Pyrsopoulos N.; Acetaminophen-Induced Hepatotoxicity: A Comprehensive Update. J Clin Transl Hepatol  2016,4(2),131-142","journal-title":"J Clin Transl Hepatol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/FPC.0000000000000150","volume":"25","author":"Mazaleuskaya L.L.","year":"2015","unstructured":"Mazaleuskaya L.L.; Sangkuhl K.; Thorn C.F.; FitzGerald G.A.; Altman R.B.; Klein T.E.; PharmGKB summary. Pharmacogenet Genomics  2015,25(8),416-426","journal-title":"Pharmacogenet Genomics"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ccc.2012.07.006","volume":"28","author":"Hodgman M.J.","year":"2012","unstructured":"Hodgman M.J.; Garrard A.R.; A review of acetaminophen poisoning. Crit Care Clin  2012,28(4),499-516","journal-title":"Crit Care Clin"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1081\/DMR-200033494","volume":"36","author":"Hinson J.A.","year":"2004","unstructured":"Hinson J.A.; Reid A.B.; McCullough S.S.; James L.P.; Acetaminophen-induced hepatotoxicity: Role of metabolic activation, reactive oxygen\/nitrogen species, and mitochondrial permeability transition. Drug Metab Rev  2004,36(3-4),805-822","journal-title":"Drug Metab Rev"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/toxsci\/kfs117","volume":"127","author":"Dragomir A.C.","year":"2012","unstructured":"Dragomir A.C.; Sun R.; Mishin V.; Hall L.B.; Laskin J.D.; Laskin D.L.; Role of galectin-3 in acetaminophen-induced hepatotoxicity and inflammatory mediator production. Toxicol Sci  2012,127(2),609-619","journal-title":"Toxicol Sci"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"828565","DOI":"10.3389\/fphar.2022.828565","volume":"13","author":"Licata A.","year":"2022","unstructured":"Licata A.; Minissale M.G.; Stankevi\u010di\u016bt\u0117 S.; Sanabria-Cabrera J.; Lucena M.I.; Andrade R.J.; Almasio P.L.; N-Acetylcysteine for preventing acetaminophen-induced liver injury: A comprehensive review. Front Pharmacol  2022,13,828565","journal-title":"Front Pharmacol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/15563650802665587","volume":"47","author":"Sandilands E.A.","year":"2009","unstructured":"Sandilands E.A.; Bateman D.N.; Adverse reactions associated with acetylcysteine. Clin Toxicol  2009,47(2),81-88","journal-title":"Clin Toxicol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1027731","DOI":"10.3389\/fphar.2022.1027731","volume":"13","author":"Zhong Y.","year":"2022","unstructured":"Zhong Y.; Chen Y.; Pan Z.; Tang K.; Zhong G.; Guo J.; Cui T.; Li T.; Duan S.; Yang X.; Gao Y.; Wang Q.; Zhang D.; Ginsenoside Rc, as an FXR activator, alleviates acetaminophen-induced hepatotoxicity via  relieving inflammation and oxidative stress. Front Pharmacol  2022,13,1027731","journal-title":"Front Pharmacol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"9128","DOI":"10.1039\/D1FO02081A","volume":"12","author":"Qu L.","year":"2021","unstructured":"Qu L.; Fu R.; Ma X.; Fan D.; Hepatoprotective effects of ginsenoside Rk3 in acetaminophen-induced liver injury in mice by activation of autophagy. Food Funct  2021,12(19),9128-9140","journal-title":"Food Funct"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.yrtph.2018.07.012","volume":"98","author":"Ning C.","year":"2018","unstructured":"Ning C.; Gao X.; Wang C.; Kong Y.; Liu Z.; Sun H.; Sun P.; Huo X.; Ma X.; Meng Q.; Liu K.; Ginsenoside Rg1 protects against acetaminophen-induced liver injury via  activating Nrf2 signaling pathway in vivo and in vitro. Regul Toxicol Pharmacol  2018,98,58-68","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"9226","DOI":"10.1021\/acs.jafc.7b03361","volume":"65","author":"Wang Z.","year":"2017","unstructured":"Wang Z.; Hu J.; Yan M.; Xing J.; Liu W.; Li W.; Caspase-mediated anti-apoptotic effect of ginsenoside rg5, a main rare ginsenoside, on acetaminophen-induced hepatotoxicity in mice. J Agric Food Chem  2017,65(42),9226-9236","journal-title":"J Agric Food Chem"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jgr.2017.07.003","volume":"43","author":"Hu J.N.","year":"2019","unstructured":"Hu J.N.; Xu X.Y.; Li W.; Wang Y.M.; Liu Y.; Wang Z.; Wang Y.P.; Ginsenoside Rk1 ameliorates paracetamol-induced hepatotoxicity in mice through inhibition of inflammation, oxidative stress, nitrative stress and apoptosis. J Ginseng Res  2019,43(1),10-19","journal-title":"J Ginseng Res"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/jpp\/rgaa069","volume":"73","author":"Gao Y.","year":"2021","unstructured":"Gao Y.; Yan J.; Li J.; Li X.; Yang S.; Chen N.; Li L.; Zhang L.; Ginsenoside Rg3 ameliorates acetaminophen-induced hepatotoxicity by suppressing inflammation and oxidative stress. J Pharm Pharmacol  2021,73(3),322-331","journal-title":"J Pharm Pharmacol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/liv.12046","volume":"33","author":"Gum S.I.","year":"2013","unstructured":"Gum S.I.; Cho M.K.; Korean red ginseng extract prevents APAP \u2010induced hepatotoxicity through metabolic enzyme regulation: The role of ginsenoside Rg3, a protopanaxadiol. Liver Int  2013,33(7),1071-1084","journal-title":"Liver Int"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/jphp.12342","volume":"67","author":"Igami K.","year":"2015","unstructured":"Igami K.; Shimojo Y.; Ito H.; Miyazaki T.; Kashiwada Y.; Hepatoprotective effect of fermented ginseng and its major constituent compound K in a rat model of paracetamol (acetaminophen)-induced liver injury. J Pharm Pharmacol  2015,67(4),565-572","journal-title":"J Pharm Pharmacol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1021\/acs.jafc.7b00610","volume":"65","author":"Xu X.Y.","year":"2017","unstructured":"Xu X.Y.; Hu J.N.; Liu Z.; Zhang R.; He Y.F.; Hou W.; Wang Z.Q.; Yang G.; Li W.; Saponins (Ginsenosides) from the Leaves of Panax quinquefolius ameliorated acetaminophen-induced hepatotoxicity in mice. J Agric Food Chem  2017,65(18),3684-3692","journal-title":"J Agric Food Chem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"664","DOI":"10.3390\/molecules22040664","volume":"22","author":"Hu J.N.","year":"2017","unstructured":"Hu J.N.; Liu Z.; Wang Z.; Li X.D.; Zhang L.X.; Li W.; Wang Y.P.; Ameliorative effects and possible molecular mechanism of action of black ginseng (panax ginseng) on acetaminophen-mediated liver injury. Molecules  2017,22(4),664","journal-title":"Molecules"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.phymed.2018.09.234","volume":"51","author":"Xu X.Y.","year":"2018","unstructured":"Xu X.Y.; Wang Z.; Ren S.; Leng J.; Hu J.; Liu Z.; Chen C.; Li W.; Improved protective effects of American ginseng berry against acetaminophen-induced liver toxicity through TNF-\u03b1-mediated caspase-3\/-8\/-9 signaling pathways. Phytomedicine  2018,51,128-138","journal-title":"Phytomedicine"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"112177","DOI":"10.1016\/j.biopha.2021.112177","volume":"143","author":"Yao F.","year":"2021","unstructured":"Yao F.; Wang X.; Cao X.; Zhang K.; Sun J.; Li Y.; Sui J.; Liu Y.; Integration of transcriptomics and metabolomics confirmed hepatoprotective effects of steamed shoot extracts of ginseng (Panax ginseng C.A. Meyer) on toxicity caused by overdosed acetaminophen. Biomed Pharmacother  2021,143,112177","journal-title":"Biomed Pharmacother"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"e13816","DOI":"10.1111\/jfbc.13816","volume":"45","author":"Bi Y.","year":"2021","unstructured":"Bi Y.; Li Q.; Tao W.; Tang J.; You G.; Yu L.; Ginsenoside Rg1 and ginsenoside Rh1 prevent liver injury induced by acetaminophen in mice. J Food Biochem  2021,45(8),e13816","journal-title":"J Food Biochem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1142\/S0192415X19500927","volume":"47","author":"Ren S.","year":"2019","unstructured":"Ren S.; Leng J.; Xu X.Y.; Jiang S.; Wang Y.P.; Yan X.T.; Liu Z.; Chen C.; Wang Z.; Li W.; Ginsenoside Rb1, A major saponin from panax ginseng, exerts protective effects against acetaminophen-induced hepatotoxicity in mice. Am J Chin Med  2019,47(8),1815-1831","journal-title":"Am J Chin Med"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1080\/10286020.2018.1504024","volume":"21","author":"Gao Y.","year":"2019","unstructured":"Gao Y.; Chu S.F.; Zhang Z.; Ai Q.D.; Xia C.Y.; Huang H.Y.; Chen N.H.; Ginsenoside Rg1 prevents acetaminophen-induced oxidative stress and apoptosis via  Nrf2\/ARE signaling pathway. J Asian Nat Prod Res  2019,21(8),782-797","journal-title":"J Asian Nat Prod Res"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.intimp.2018.03.030","volume":"59","author":"Zhou Y.","year":"2018","unstructured":"Zhou Y.; Hou J.; Liu W.; Ren S.; Wang Y.; Zhang R.; Chen C.; Wang Z.; Li W.; 20(R)-ginsenoside Rg3, a rare saponin from red ginseng, ameliorates acetaminophen-induced hepatotoxicity by suppressing PI3K\/AKT pathway-mediated inflammation and apoptosis. Int Immunopharmacol  2018,59,21-30","journal-title":"Int Immunopharmacol"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.toxlet.2018.03.023","volume":"290","author":"Darwish M.A.","year":"2018","unstructured":"Darwish M.A.; Abo-Youssef A.M.; Khalaf M.M.; Abo-Saif A.A.; Saleh I.G.; Abdelghany T.M.; Resveratrol influences platinum pharmacokinetics: A novel mechanism in protection against cisplatin-induced nephrotoxicity. Toxicol Lett  2018,290,73-82","journal-title":"Toxicol Lett"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1039\/C8FO00653A","volume":"9","author":"Neamatallah T.","year":"2018","unstructured":"Neamatallah T.; El-Shitany N.A.; Abbas A.T.; Ali S.S.; Eid B.G.; Honey protects against cisplatin-induced hepatic and renal toxicity through inhibition of NF-\u03baB-mediated COX-2 expression and the oxidative stress dependent BAX\/Bcl-2\/caspase-3 apoptotic pathway. Food Funct  2018,9(7),3743-3754","journal-title":"Food Funct"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"e0151649","DOI":"10.1371\/journal.pone.0151649","volume":"11","author":"Omar H.A.","year":"2016","unstructured":"Omar H.A.; Mohamed W.R.; Arab H.H.; Arafa E.S.A.; Tangeretin alleviates cisplatin-induced acute hepatic injury in rats: Targeting MAPKs and apoptosis. PLoS One  2016,11(3),e0151649","journal-title":"PLoS One"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3109\/10408441003601836","volume":"40","author":"Brozovic A.","year":"2010","unstructured":"Brozovic A.; Ambriovi\u0107-Ristov A.; Osmak M.; The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin. Crit Rev Toxicol  2010,40(4),347-359","journal-title":"Crit Rev Toxicol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00204-020-02689-3","volume":"94","author":"Gulcin \u0130.","year":"2020","unstructured":"Gulcin \u0130.; Antioxidants and antioxidant methods: An updated overview. Arch Toxicol  2020,94(3),651-715","journal-title":"Arch Toxicol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1021\/acs.chemrestox.9b00204","volume":"32","author":"Qi L.","year":"2019","unstructured":"Qi L.; Luo Q.; Zhang Y.; Jia F.; Zhao Y.; Wang F.; Advances in toxicological research of the anticancer drug cisplatin. Chem Res Toxicol  2019,32(8),1469-1486","journal-title":"Chem Res Toxicol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/10715762.2016.1234710","volume":"51","author":"Gao Y.","year":"2017","unstructured":"Gao Y.; Chu S.; Shao Q.; Zhang M.; Xia C.; Wang Y.; Li Y.; Lou Y.; Huang H.; Chen N.; Antioxidant activities of ginsenoside Rg1 against cisplatin-induced hepatic injury through Nrf2 signaling pathway in mice. Free Radic Res  2017,51(1),1-13","journal-title":"Free Radic Res"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1016\/j.fct.2012.01.005","volume":"50","author":"Lee C.K.","year":"2012","unstructured":"Lee C.K.; Park K.K.; Chung A.S.; Chung W.Y.; Ginsenoside Rg3 enhances the chemosensitivity of tumors to cisplatin by reducing the basal level of nuclear factor erythroid 2-related factor 2-mediated heme oxygenase-1\/NAD(P)H quinone oxidoreductase-1 and prevents normal tissue damage by scavenging cisplatin-induced intracellular reactive oxygen species. Food Chem Toxicol  2012,50(7),2565-2574","journal-title":"Food Chem Toxicol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","volume":"16","author":"Perucca E.","year":"2002","unstructured":"Perucca E.; Pharmacological and therapeutic properties of valproate: A summary after 35 years of clinical experience. CNS Drugs  2002,16(10),695-714","journal-title":"CNS Drugs"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1007\/s00018-007-7079-x","volume":"64","author":"Rosenberg G.","year":"2007","unstructured":"Rosenberg G.; The mechanisms of action of valproate in neuropsychiatric disorders: Can we see the forest for the trees? Cell Mol Life Sci  2007,64(16),2090-2103","journal-title":"Cell Mol Life Sci"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"103967","DOI":"10.1016\/j.etap.2022.103967","volume":"95","author":"Ezhilarasan D.","year":"2022","unstructured":"Ezhilarasan D.; Mani U.; Valproic acid induced liver injury: An insight into molecular toxicological mechanism. Environ Toxicol Pharmacol  2022,95,103967","journal-title":"Environ Toxicol Pharmacol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pediatrneurol.2017.09.013","volume":"77","author":"Vidaurre J.","year":"2017","unstructured":"Vidaurre J.; Gedela S.; Yarosz S.; Antiepileptic drugs and liver disease. Pediatr Neurol  2017,77,23-36","journal-title":"Pediatr Neurol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/toxsci\/kfi184","volume":"86","author":"Tong V.","year":"2005","unstructured":"Tong V.; Teng X.W.; Chang T.K.H.; Abbott F.S.; Valproic acid I: Time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolite levels in rats. Toxicol Sci  2005,86(2),427-435","journal-title":"Toxicol Sci"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3109\/15376516.2013.821567","volume":"23","author":"Jafarian I.","year":"2013","unstructured":"Jafarian I.; Eskandari M.R.; Mashayekhi V.; Ahadpour M.; Hosseini M.J.; Toxicity of valproic acid in isolated rat liver mitochondria. Toxicol Mech Methods  2013,23(8),617-623","journal-title":"Toxicol Mech Methods"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"114829","DOI":"10.1016\/j.taap.2019.114829","volume":"386","author":"Zhou L.","year":"2020","unstructured":"Zhou L.; Chen L.; Zeng X.; Liao J.; Ouyang D.; Ginsenoside compound K alleviates sodium valproate-induced hepatotoxicity in rats via  antioxidant effect, regulation of peroxisome pathway and iron homeostasis. Toxicol Appl Pharmacol  2020,386,114829","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"115555","DOI":"10.1016\/j.taap.2021.115555","volume":"422","author":"Zhou L.","year":"2021","unstructured":"Zhou L.; Zeng X.; Rao T.; Tan Z.; Zhou G.; Ouyang D.; Chen L.; Evaluating the protective effects of individual or combined ginsenoside compound K and the downregulation of soluble epoxide hydrolase expression against sodium valproate-induced liver cell damage. Toxicol Appl Pharmacol  2021,422,115555","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.cld.2020.04.008","volume":"24","author":"Cheung A.","year":"2020","unstructured":"Cheung A.; Kwo P.; Viral hepatitis other than A, B, and C. Clin Liver Dis  2020,24(3),405-419","journal-title":"Clin Liver Dis"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nature13806","volume":"517","author":"Wang X.","year":"2015","unstructured":"Wang X.; Ren J.; Gao Q.; Hu Z.; Sun Y.; Li X.; Rowlands D.J.; Yin W.; Wang J.; Stuart D.I.; Rao Z.; Fry E.E.; Hepatitis A virus and the origins of picornaviruses. Nature  2015,517(7532),85-88","journal-title":"Nature"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/4263309","volume":"2023","author":"Gholizadeh O.","year":"2023","unstructured":"Gholizadeh O.; Akbarzadeh S.; Ghazanfari Hashemi M.; Gholami M.; Amini P.; Yekanipour Z.; Tabatabaie R.; Yasamineh S.; Hosseini P.; Poortahmasebi V.; Hepatitis A.; Viral structure, classification, life cycle, clinical symptoms, diagnosis error, and vaccination. Can J Infect Dis Med Microbiol  2023,2023,1-17","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"M1412","DOI":"10.1111\/1750-3841.12205","volume":"78","author":"Lee M.H.","year":"2013","unstructured":"Lee M.H.; Lee B.H.; Lee S.; Choi C.; Reduction of hepatitis A virus on FRhK-4 cells treated with Korean red ginseng extract and ginsenosides. J Food Sci  2013,78(9),M1412-M1415","journal-title":"J Food Sci"},{"key":"ref=114","first-page":"S1","volume":"101","author":"Wright T.L.","year":"2006","unstructured":"Wright T.L.; Introduction to chronic hepatitis B infection. Am J Gastroenterol  2006,101,S1-S6","journal-title":"Am J Gastroenterol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cld.2019.04.008","volume":"23","author":"Vittal A.","year":"2019","unstructured":"Vittal A.; Ghany M.G.; WHO guidelines for prevention, care and treatment of individuals infected with HBV. Clin Liver Dis  2019,23(3),417-432","journal-title":"Clin Liver Dis"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/14787210.2018.1428561","volume":"16","author":"Vigan\u00f2 M.","year":"2018","unstructured":"Vigan\u00f2 M.; Loglio A.; Grossi G.; Lampertico P.; Tenofovir alafenamide (TAF) treatment of HBV, what are the unanswered questions? Expert Rev Anti Infect Ther  2018,16(2),153-161","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"e10465","DOI":"10.1016\/j.heliyon.2022.e10465","volume":"8","author":"Duraisamy G.S.","year":"2022","unstructured":"Duraisamy G.S.; Jo E.; Huvarov\u00e1 I.; Park K.H.P.; Heger Z.; Adam V.; R\u016f\u017eek D.; Windisch M.P.; Miller A.D.; Selected ginsenosides interfere efficiently with hepatitis B virus mRNA expression levels and suppress viral surface antigen secretion. Heliyon  2022,8(9),e10465","journal-title":"Heliyon"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1016\/j.biocel.2013.08.016","volume":"45","author":"Kang L.J.","year":"2013","unstructured":"Kang L.J.; Choi Y.J.; Lee S.G.; Stimulation of TRAF6\/TAK1 degradation and inhibition of JNK\/AP-1 signalling by ginsenoside Rg3 attenuates hepatitis B virus replication. Int J Biochem Cell Biol  2013,45(11),2612-2621","journal-title":"Int J Biochem Cell Biol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1139\/cjpp-2015-0528","volume":"94","author":"Yuan D.","year":"2016","unstructured":"Yuan D.; Yuan Q.; Cui Q.; Liu C.; Zhou Z.; Zhao H.; Dun Y.; Wang T.; Zhang C.; Vaccine adjuvant ginsenoside Rg1 enhances immune responses against hepatitis B surface antigen in mice. Can J Physiol Pharmacol  2016,94(6),676-681","journal-title":"Can J Physiol Pharmacol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1053\/j.gastro.2010.12.032","volume":"140","author":"Kanwal F.","year":"2011","unstructured":"Kanwal F.; Hoang T.; Kramer J.R.; Asch S.M.; Goetz M.B.; Zeringue A.; Richardson P.; El-Serag H.B.; Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology  2011,140(4),1182-1188.e1","journal-title":"Gastroenterology"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"e2011055","DOI":"10.1001\/jamanetworkopen.2020.11055","volume":"3","author":"Kalidindi Y.","year":"2020","unstructured":"Kalidindi Y.; Association of direct-acting antiviral treatment with mortality among medicare beneficiaries with hepatitis C. JAMA Netw Open  2020,3(7),e2011055","journal-title":"JAMA Netw Open"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/hep.29177","volume":"66","author":"Kim S.J.","year":"2017","unstructured":"Kim S.J.; Jang J.Y.; Kim E.J.; Cho E.K.; Ahn D.G.; Kim C.; Park H.S.; Jeong S.W.; Lee S.H.; Kim S.G.; Kim Y.S.; Kim H.S.; Kim B.S.; Lee J.; Siddiqui A.; Ginsenoside Rg3 restores hepatitis C virus\u2013induced aberrant mitochondrial dynamics and inhibits virus propagation. Hepatology  2017,66(3),758-771","journal-title":"Hepatology"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/S0002-9610(00)00573-0","volume":"181","author":"Serracino-Inglott F.","year":"2001","unstructured":"Serracino-Inglott F.; Habib N.A.; Mathie R.T.; Hepatic ischemia-reperfusion injury. Am J Surg  2001,181(2),160-166","journal-title":"Am J Surg"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6486109","volume":"2021","author":"Zhang K.","year":"2021","unstructured":"Zhang K.; Li J.; Li Y.; Ginsenoside Rg1 alleviates hepatic ischemia-reperfusion injury in mice via  activating ER\u03b1-Regulating YAP Expression. Evid Based Complement Alternat Med  2021,2021,1-9","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"110398","DOI":"10.1016\/j.biopha.2020.110398","volume":"129","author":"Lin J.","year":"2020","unstructured":"Lin J.; Huang H.; Yang S.; Duan J.; Qu S.; Yuan B.; Zeng Z.; The effect of Ginsenoside Rg1 in hepatic ischemia reperfusion (I\/R) injury ameliorates ischemia-reperfusion-induced liver injury by inhibiting apoptosis. Biomed Pharmacother  2020,129,110398","journal-title":"Biomed Pharmacother"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jss.2014.03.067","volume":"191","author":"Tao T.","year":"2014","unstructured":"Tao T.; Chen F.; Bo L.; Xie Q.; Yi W.; Zou Y.; Hu B.; Li J.; Deng X.; Ginsenoside Rg1 protects mouse liver against ischemia\u2013reperfusion injury through anti-inflammatory and anti-apoptosis properties. J Surg Res  2014,191(1),231-238","journal-title":"J Surg Res"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3858\/emm.2008.40.6.686","volume":"40","author":"Wang J.","year":"2008","unstructured":"Wang J.; Qiao L.; Li Y.; Yang G.; Ginsenoside Rb1 attenuates intestinal ischemia-reperfusion-induced liver injury by inhibiting NF-\u03baB activation. Exp Mol Med  2008,40(6),686-698","journal-title":"Exp Mol Med"},{"key":"ref=128","year":"2019","unstructured":"W.H.O. Global status report on alcohol and health 2018; World\tHealth Organization,  2019"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","volume":"4","author":"Seitz H.K.","year":"2018","unstructured":"Seitz H.K.; Bataller R.; Cortez-Pinto H.; Gao B.; Gual A.; Lackner C.; Mathurin P.; Mueller S.; Szabo G.; Tsukamoto H.; Alcoholic liver disease. Nat Rev Dis Primers  2018,4(1),16","journal-title":"Nat Rev Dis Primers"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"178","DOI":"10.4161\/oxim.3.3.12288","volume":"3","author":"Setshedi M.","year":"2010","unstructured":"Setshedi M.; Wands J.R.; de la Monte S.M.; Acetaldehyde adducts in alcoholic liver disease. Oxid Med Cell Longev  2010,3(3),178-185","journal-title":"Oxid Med Cell Longev"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.cld.2016.02.004","volume":"20","author":"Dunn W.","year":"2016","unstructured":"Dunn W.; Shah V.H.; Pathogenesis of alcoholic liver disease. Clin Liver Dis  2016,20(3),445-456","journal-title":"Clin Liver Dis"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.3390\/ijms20112712","volume":"20","author":"Kong L.Z.","year":"2019","unstructured":"Kong L.Z.; Chandimali N.; Han Y.H.; Lee D.H.; Kim J.S.; Kim S.U.; Kim T.D.; Jeong D.K.; Sun H.N.; Lee D.S.; Kwon T.; Pathogenesis, early diagnosis, and therapeutic management of alcoholic liver disease. Int J Mol Sci  2019,20(11),2712","journal-title":"Int J Mol Sci"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"616409","DOI":"10.3389\/fphar.2021.616409","volume":"12","author":"Lai Y.","year":"2021","unstructured":"Lai Y.; Tan Q.; Xv S.; Huang S.; Wang Y.; Li Y.; Zeng T.; Mo C.; Chen Y.; Huang S.; Zhou C.; Gao L.; Lv Z.; Ginsenoside Rb1 alleviates alcohol-induced liver injury by inhibiting steatosis, oxidative stress, and inflammation. Front Pharmacol  2021,12,616409","journal-title":"Front Pharmacol"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"14220","DOI":"10.1021\/acs.jafc.2c06146","volume":"70","author":"Pan Z.","year":"2022","unstructured":"Pan Z.; Guo J.; Tang K.; Chen Y.; Gong X.; Chen Y.; Zhong Y.; Xiao X.; Duan S.; Cui T.; Wu X.; Zhong Y.; Yang X.; Shen C.; Gao Y.; Ginsenoside Rc modulates SIRT6-NRF2 interaction to alleviate alcoholic liver disease. J Agric Food Chem  2022,70(44),14220-14234","journal-title":"J Agric Food Chem"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"107327","DOI":"10.1016\/j.intimp.2020.107327","volume":"92","author":"Yang C.","year":"2021","unstructured":"Yang C.; He X.; Zhao J.; Huang W.; Hepatoprotection by Ginsenoside Rg1 in alcoholic liver disease. Int Immunopharmacol  2021,92,107327","journal-title":"Int Immunopharmacol"},{"key":"ref=136","first-page":"899","volume":"41","author":"Li J.","year":"2018","unstructured":"Li J.; Yang C.; Zhang S.; Liu S.; Zhao L.; Luo H.; Chen Y.; Huang W.; Ginsenoside Rg1 inhibits inflammatory responses via  modulation of the nuclear factor \u03baB pathway and inhibition of inflammasome activation in alcoholic hepatitis. Int J Mol Med  2018,41(2),899-907","journal-title":"Int J Mol Med"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jep.2015.07.020","volume":"173","author":"Gao Y.","year":"2015","unstructured":"Gao Y.; Chu S.; Li J.; Li J.; Zhang Z.; Xia C.; Heng Y.; Zhang M.; Hu J.; Wei G.; Li Y.; Chen N.; Anti-inflammatory function of ginsenoside Rg1 on alcoholic hepatitis through glucocorticoid receptor related nuclear factor-kappa B pathway. J Ethnopharmacol  2015,173,231-240","journal-title":"J Ethnopharmacol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.fct.2019.02.032","volume":"126","author":"Qu L.","year":"2019","unstructured":"Qu L.; Zhu Y.; Liu Y.; Yang H.; Zhu C.; Ma P.; Deng J.; Fan D.; Protective effects of ginsenoside Rk3 against chronic alcohol-induced liver injury in mice through inhibition of inflammation, oxidative stress, and apoptosis. Food Chem Toxicol  2019,126,277-284","journal-title":"Food Chem Toxicol"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.jgr.2020.03.002","volume":"44","author":"Kim M.H.","year":"2020","unstructured":"Kim M.H.; Kim H.H.; Jeong J.M.; Shim Y.R.; Lee J.H.; Kim Y.E.; Ryu T.; Yang K.; Kim K.R.; Jeon B.M.; Kim S.C.; Jung J.K.; Choi J.K.; Lee Y.S.; Byun J.S.; Jeong W.I.; Ginsenoside F2 attenuates chronic-binge ethanol-induced liver injury by increasing regulatory T cells and decreasing Th17 cells. J Ginseng Res  2020,44(6),815-822","journal-title":"J Ginseng Res"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1021\/acs.jafc.2c06804","volume":"71","author":"Chen Y.","year":"2023","unstructured":"Chen Y.; Lin L.; Yang C.; Li T.; Li Y.; Wang J.; Wu Y.; Zhao Y.; Su G.; Ginsenoside AD-2 ameliorating lipopolysaccharide-induced activation in HSC-T6 Cells and carbon tetrachloride-induced hepatic fibrosis in mice via  regulation of VD-VDR Axis. J Agric Food Chem  2023,71(7),3459-3471","journal-title":"J Agric Food Chem"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","volume":"115","author":"Bataller R.","year":"2005","unstructured":"Bataller R.; Brenner D.A.; Liver fibrosis. J Clin Invest  2005,115(2),209-218","journal-title":"J Clin Invest"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"Kisseleva T.","year":"2021","unstructured":"Kisseleva T.; Brenner D.; Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol  2021,18(3),151-166","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/biof.1432","volume":"44","author":"Wei X.","year":"2018","unstructured":"Wei X.; Chen Y.; Huang W.; Ginsenoside Rg1 ameliorates liver fibrosis via  suppressing epithelial to mesenchymal transition and reactive oxygen species production in vitro and in vivo. Biofactors  2018,44(4),327-335","journal-title":"Biofactors"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.bbadis.2013.02.019","volume":"1832","author":"Lemoinne S.","year":"2013","unstructured":"Lemoinne S.; Cadoret A.; El Mourabit H.; Thabut D.; Housset C.; Origins and functions of liver myofibroblasts. Biochim Biophys Acta Mol Basis Dis  2013,1832(7),948-954","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/cells9040875","volume":"9","author":"Roehlen N.","year":"2020","unstructured":"Roehlen N.; Crouchet E.; Baumert T.F.; Liver fibrosis: Mechanistic concepts and therapeutic perspectives. Cells  2020,9(4),875","journal-title":"Cells"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"173578","DOI":"10.1016\/j.ejphar.2020.173578","volume":"888","author":"Ma X.","year":"2020","unstructured":"Ma X.; Jiang Y.; Wen J.; Zhao Y.; Zeng J.; Guo Y.; A comprehensive review of natural products to fight liver fibrosis: Alkaloids, terpenoids, glycosides, coumarins and other compounds. Eur J Pharmacol  2020,888,173578","journal-title":"Eur J Pharmacol"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1021\/acs.jafc.1c07578","volume":"70","author":"He Z.","year":"2022","unstructured":"He Z.; Chen S.; Pan T.; Li A.; Wang K.; Lin Z.; Liu W.; Wang Y.; Wang Y.; Ginsenoside Rg2 Ameliorating CDAHFD-induced hepatic fibrosis by regulating akt\/mtor-mediated autophagy. J Agric Food Chem  2022,70(6),1911-1922","journal-title":"J Agric Food Chem"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"154121","DOI":"10.1016\/j.phymed.2022.154121","volume":"101","author":"Chen S.","year":"2022","unstructured":"Chen S.; He Z.; Xie W.; Chen X.; Lin Z.; Ma J.; Liu Z.; Yang S.; Wang Y.; Ginsenoside Rh2 attenuates CDAHFD-induced liver fibrosis in mice by improving intestinal microbial composition and regulating LPS-mediated autophagy. Phytomedicine  2022,101,154121","journal-title":"Phytomedicine"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.ijbiomac.2021.11.098","volume":"194","author":"Yuan S.","year":"2022","unstructured":"Yuan S.; Dong M.; Zhang H.; Jiang X.; Yan C.; Ye R.; Zhou H.; Chen L.; Lian H.; Jin W.; Ginsenoside PPD inhibit the activation of HSCs by directly targeting TGF\u03b2R1. Int J Biol Macromol  2022,194,556-562","journal-title":"Int J Biol Macromol"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41419-020-2597-7","volume":"11","author":"Liu X.","year":"2020","unstructured":"Liu X.; Mi X.; Wang Z.; Zhang M.; Hou J.; Jiang S.; Wang Y.; Chen C.; Li W.; Ginsenoside Rg3 promotes regression from hepatic fibrosis through reducing inflammation-mediated autophagy signaling pathway. Cell Death Dis  2020,11(6),454","journal-title":"Cell Death Dis"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/1472-6882-14-415","volume":"14","author":"Hou Y.L.","year":"2014","unstructured":"Hou Y.L.; Tsai Y.H.; Lin Y.H.; Chao J.C.J.; Ginseng extract and ginsenoside Rb1 attenuate carbon tetrachloride-induced liver fibrosis in rats. BMC Complement Altern Med  2014,14(1),415","journal-title":"BMC Complement Altern Med"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"154950","DOI":"10.1016\/j.phymed.2023.154950","volume":"118","author":"Lang Z.","year":"2023","unstructured":"Lang Z.; Yu S.; Hu Y.; Tao Q.; Zhang J.; Wang H.; Zheng L.; Yu Z.; Zheng J.; Ginsenoside Rh2 promotes hepatic stellate cell ferroptosis and inactivation via  regulation of IRF1-inhibited SLC7A11. Phytomedicine  2023,118,154950","journal-title":"Phytomedicine"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010291326240214095327","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/227496\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0113892010291326240214095327","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T11:41:19Z","timestamp":1747741279000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/227496\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":152,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0113892010291326240214095327","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-12-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}